Development and characterization of [47Sc]Sc-NOTA-trastuzumab for targeted radiotherapy in primary and metastatic HER2 + breast cancer.
Saved in:
| Title: | Development and characterization of [47Sc]Sc-NOTA-trastuzumab for targeted radiotherapy in primary and metastatic HER2 + breast cancer. |
|---|---|
| Authors: | Song PN; Department of Radiology, The University of Alabama at Birmingham, Birmingham, USA; Graduate Biomedical Sciences, The University of Alabama at Birmingham, Birmingham, USA., Cingoranelli SJ; Department of Radiology, The University of Alabama at Birmingham, Birmingham, USA; Department of Chemistry, The University of Alabama at Birmingham, Birmingham, USA., Sridhar S; Department of Radiology, The University of Alabama at Birmingham, Birmingham, USA., Houson HA; Department of Radiology, The University of Alabama at Birmingham, Birmingham, USA; Department of Chemistry, The University of Alabama at Birmingham, Birmingham, USA., Gallegos CA; Department of Radiology, The University of Alabama at Birmingham, Birmingham, USA; Department of Biomedical Engineering, The University of Alabama at Birmingham, Birmingham, USA., Watts LB; Department of Radiology, The University of Alabama at Birmingham, Birmingham, USA., Bartels JL; Department of Chemistry, The University of Alabama at Birmingham, Birmingham, USA., Willey CD; Department of Radiation Oncology, The University of Alabama at Birmingham, Birmingham, USA; O'Neal Comprehensive Cancer Center, The University of Alabama at Birmingham, Birmingham, USA., Lapi SE; Department of Radiology, The University of Alabama at Birmingham, Birmingham, USA; Department of Chemistry, The University of Alabama at Birmingham, Birmingham, USA; O'Neal Comprehensive Cancer Center, The University of Alabama at Birmingham, Birmingham, USA. Electronic address: lapi@uab.edu., Sorace AG; Department of Radiology, The University of Alabama at Birmingham, Birmingham, USA; Department of Biomedical Engineering, The University of Alabama at Birmingham, Birmingham, USA; O'Neal Comprehensive Cancer Center, The University of Alabama at Birmingham, Birmingham, USA. Electronic address: asorace@uabmc.edu. |
| Source: | Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie [Biomed Pharmacother] 2026 Jul 21; Vol. 202, pp. 119736. Date of Electronic Publication: 2026 Jul 21. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Editions Scientifiques Elsevier Country of Publication: France NLM ID: 8213295 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1950-6007 (Electronic) Linking ISSN: 07533322 NLM ISO Abbreviation: Biomed Pharmacother Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
